Carson Wealth (CWM LLC)
TTNP

Carson Wealth (CWM LLC)’s Titan Pharmaceuticals TTNP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed – – 5646
2025
Q3 		$0 Buy
+1
New +$4 ﹤0.01% 5555
2023
Q3 		– Hold
0
– – – 4536
2023
Q2 		– Hold
0
– – – 4464
2023
Q1 		– Hold
0
– – – 4347

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TTNP Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 1 share.

Carson Wealth (CWM LLC) first reported a position in TTNP in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 1 Titan Pharmaceuticals share in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Titan Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Carson Wealth (CWM LLC)'s Titan Pharmaceuticals position peaked at $0 in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.